CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

CMG Pharmaceutical Revenue

CMG Pharmaceutical had revenue of 30.40B KRW in the quarter ending September 30, 2025, with 23.01% growth. This brings the company's revenue in the last twelve months to 100.41B, up 6.41% year-over-year. In the year 2024, CMG Pharmaceutical had annual revenue of 99.10B with 5.53% growth.

• Revenue (ttm): 100.41B
• Revenue Growth: +6.41%
• P/S Ratio: 2.93
• Revenue / Employee: 450.29M
• Employees: 223
• Market Cap: 294.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	99.10B	5.19B	5.53%
Dec 31, 2023	93.91B	11.71B	14.25%
Dec 31, 2022	82.20B	23.57B	40.21%
Dec 31, 2019	58.62B	8.76B	17.56%
Dec 31, 2018	49.86B	8.33B	20.05%